BSc3094 is primarily utilized in the field of pharmaceutical research as a potential therapeutic agent. It has shown promising activity in targeting specific cellular pathways, making it a candidate for the development of treatments for certain types of cancers. Researchers are investigating its efficacy in inhibiting tumor growth and its potential to enhance the effectiveness of existing chemotherapy regimens. Additionally, BSc3094 is being studied for its role in modulating immune responses, which could lead to applications in autoimmune diseases or immunotherapy. Its unique mechanism of action makes it a valuable compound in preclinical studies aimed at understanding disease mechanisms and discovering novel drug candidates.